Jan 02, 2019
The promise and dangers of editing the genome of a human embryo are being discussed by scientists around the world. They are contemplating whether it should be allowed or not— and if so, under what circumstances? The meetings have been prompted by the powerful technology known as CRISPR/Cas9. This could be use...
Read More...
LEQEMBI: A New Hope for Alzheimer’s Disease Patients
Feb 12, 2025
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Newsletter/Whitepaper